Company news
Lexicon Pharmaceuticals, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer
December 2, 2019
Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision From FDA’s Office of New Drugs for Sotagliflozin in Type 1 Diabetes
December 1, 2019
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update
November 6, 2019
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium
October 1, 2019
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi
September 9, 2019
Calls
The 5 newest of 25 calls. Every call is listed under its year.
- Lexicon Pharmaceuticals (NASDAQ:LXRX) Q3 2026 Earnings Call
Nov 5, 2026
Transcript - Lexicon Pharmaceuticals (NASDAQ:LXRX) Q2 2026 Earnings Call
Aug 6, 2026
Transcript - Lexicon Pharmaceuticals (NASDAQ:LXRX) Q1 2026 Earnings Call
May 7, 2026
Transcript - Lexicon Pharmaceuticals (NASDAQ:LXRX) Q4 2025 Earnings Call
Mar 5, 2026
Transcript - Lexicon Pharmaceuticals (NASDAQ:LXRX) Q3 2025 Earnings Call
Nov 6, 2025
Transcript
Decks
The 5 newest of 23 decks. Every deck is listed under its year.
- Investor Presentation (September 2026)
Investor deck · 32 slides · September 2026
- Q2 2026 Earnings Presentation
Earnings · 22 slides · Aug 6, 2026
- Q1 2026 Earnings Presentation
Earnings · 29 slides · May 7, 2026
- Q4 2025 Earnings Presentation
Earnings · 31 slides · Mar 5, 2026
- Q3 2025 Earnings Presentation
Earnings · 22 slides · Nov 6, 2025